Workflow
Elanco(ELAN)
icon
Search documents
Elanco Completes Sale of Aqua Business
Prnewswire· 2024-07-09 12:28
Transaction concentrates Elanco's focus on significant value creation opportunities and accelerates deleveraging progress "Finalizing this transaction marks a significant milestone in concentrating our focus on high-value opportunities in pet health and livestock sustainability while creating balance sheet flexibility. Elanco's positive trajectory, demonstrated by three consecutive quarters of underlying revenue growth, pipeline progress, and our ability to reduce debt, strengthens our value proposition," s ...
Elanco Animal Health (ELAN) Faces Scrutiny and Shareholder Investigation Over Delayed Product Launches – Hagens Berman
GlobeNewswire News Room· 2024-07-08 17:32
Visit: www.hbsslaw.com/investor-fraud/elan Contact the Firm Now: ELAN@hbsslaw.com | 844-916-0895 Elanco Animal Health is facing questions from investors regarding the accuracy of its previous statements concerning the commercial launch timelines for two key products. These products, Zenrelia, a dermatology treatment for pets, and Credelio Quattro, a broad-spectrum parasiticide, were positioned by Elanco as potential "blockbusters." But on June 27, 2024, Elanco significantly revised its launch timelines. The ...
ELAN INQUIRY UPDATE: Elanco (NYSE:ELAN) Investors that Lost Money are Reminded to Contact BFA Law about Securities Fraud Investigation
GlobeNewswire News Room· 2024-07-08 11:01
If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. With respect to these treatments, the company stated that the FDA "has all data necessary to complete its review. All technical sections, including the label, are expected to be approved before the end of June [2024]." However, on June 27, 2024, Elanco announced that it expected the FDA would not approve either drug in June 2024 and that Ze ...
ELAN INQUIRY UPDATE: Elanco (NYSE:ELAN) Investors that Lost Money are Reminded to Contact BFA Law about Securities Fraud Investigation
Newsfilter· 2024-07-08 11:01
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. Why Did Elanco's Stock Drop? With respect to these treatments, the company stated that the FDA "has all data necessary to complete its review. All technical sections, including the label, are expected to be approved before the end of June [2024]." However, on June 27, 2024, Ela ...
ELAN INVESTIGATION NEWS: Elanco (NYSE:ELAN) Investors that Suffered Losses are Notified to Contact BFA Law about Inquiry into the Company for Securities Fraud
Newsfilter· 2024-07-06 10:09
NEW YORK, July 06, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. Why Did Elanco's Stock Drop? Elanco develops products to treat diseases in animals. Two of the most importan ...
ELAN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Elanco Animal Health Incorporated investment
Newsfilter· 2024-07-02 16:41
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 17th Floor New York, NY 10004 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.com NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors that it has commenced an investigation of Elanco Animal Health Incorporated ("Elanco") (NYSE:ELAN) concerning possible violations of federal securities laws. https://zlk.com/pslra-1/elanco-animal-health-incorporated-lawsuit-submission ...
ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-07-02 01:00
Click here to participate in the action. On this news, Elanco's stock price fell $3.69 per share, or 20.53%, to close at $14.28 per share on June 27, 2024. About Bragar Eagel & Squire, P.C.: Contact Information: NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) on behalf of Elanco stockholders. Our investigation conce ...
ELAN INVESTIGATION NOTICE: BFA Law Alerts Investors that it is Investigating Elanco (NYSE: ELAN) for Securities Fraud; Investors who Suffered Losses are Urged to Contact the Firm
GlobeNewswire News Room· 2024-07-01 12:08
If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanco-animal-health-incorporated. With respect to these treatments, the company stated that the FDA "has all data necessary to complete its review. All technical sections, including the label, are expected to be approved before the end of June [2024]." However, on June 27, 2024, Elanco announced that it expected the FDA would not approve either drug in June 2024 and that Ze ...
ELAN INVESTIGATION ALERT: BFA Law Announces that it is Investigating Elanco (NYSE: ELAN) for Securities Fraud; Investors who Suffered Losses are Encouraged to Contact the Firm
GlobeNewswire News Room· 2024-06-28 19:22
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Elanco Animal Health Incorporated (NYSE:ELAN) for potential violations of the federal securities laws. Why Did Elanco's Stock Drop? With respect to these treatments, the company stated that the FDA "has all data necessary to complete its review. All technical sections, including the label, are expected to be approved before the end of June [2024]." However, on June 27, 2024, Ela ...
ELAN NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Elanco Animal Hospital Shareholders
GlobeNewswire News Room· 2024-06-28 14:36
SAN DIEGO, June 28, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elanco Animal Health Incorporated ("Elanco" or the "Company") (NYSE: ELAN) or any of its executive officers or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws. There is no cost or obligation to you. Johnson ...